Literature DB >> 26675679

GluN2D N-Methyl-d-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for Schizophrenia.

Kiran Sapkota1, Zhihao Mao1, Paul Synowicki1, Dillon Lieber1, Meng Liu1, Tsuneya Ikezu1, Vivek Gautam1, Daniel T Monaghan2.   

Abstract

The dissociative anesthetic ketamine elicits symptoms of schizophrenia at subanesthetic doses by blocking N-methyl-d-aspartate receptors (NMDARs). This property led to a variety of studies resulting in the now well-supported theory that hypofunction of NMDARs is responsible for many of the symptoms of schizophrenia. However, the roles played by specific NMDAR subunits in different symptom components are unknown. To evaluate the potential contribution of GluN2D NMDAR subunits to antagonist-induced cortical activation and schizophrenia symptoms, we determined the ability of ketamine to alter regional brain activity and gamma frequency band neuronal oscillations in wild-type (WT) and GluN2D-knockout (GluN2D-KO) mice. In WT mice, ketamine (30 mg/kg, i.p.) significantly increased [(14)C]-2-deoxyglucose ([(14)C]-2DG) uptake in the medial prefrontal cortex (mPFC), entorhinal cortex and other brain regions, and decreased activity in the somatosensory cortex and inferior colliculus. In GluN2D-KO mice, however, ketamine did not significantly increase [(14)C]-2DG uptake in any brain region examined, yet still decreased [(14)C]-2DG uptake in the somatosensory cortex and inferior colliculus. Ketamine also increased locomotor activity in WT mice but not in GluN2D-KO mice. In electrocorticographic analysis, ketamine induced a 111% ± 16% increase in cortical gamma-band oscillatory power in WT mice, but only a 15% ± 12% increase in GluN2D-KO mice. Consistent with GluN2D involvement in schizophrenia-related neurologic changes, GluN2D-KO mice displayed impaired spatial memory acquisition and reduced parvalbumin (PV)-immunopositive staining compared with control mice. These results suggest a critical role of GluN2D-containing NMDARs in neuronal oscillations and ketamine's psychotomimetic, dissociative effects and hence suggests a critical role for GluN2D subunits in cognition and perception.
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26675679      PMCID: PMC4767398          DOI: 10.1124/jpet.115.230391

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  88 in total

1.  Cloning and expression of the epsilon 4 subunit of the NMDA receptor channel.

Authors:  K Ikeda; M Nagasawa; H Mori; K Araki; K Sakimura; M Watanabe; Y Inoue; M Mishina
Journal:  FEBS Lett       Date:  1992-11-16       Impact factor: 4.124

2.  Effects of ketamine, MK-801, and amphetamine on regional brain 2-deoxyglucose uptake in freely moving mice.

Authors:  S Miyamoto; J N Leipzig; J A Lieberman; G E Duncan
Journal:  Neuropsychopharmacology       Date:  2000-04       Impact factor: 7.853

3.  Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine.

Authors:  Shawn E Kotermanski; Jon W Johnson
Journal:  J Neurosci       Date:  2009-03-04       Impact factor: 6.167

4.  Expression of NMDAR2D glutamate receptor subunit mRNA in neurochemically identified interneurons in the rat neostriatum, neocortex and hippocampus.

Authors:  D G Standaert; G B Landwehrmeyer; J A Kerner; J B Penney; A B Young
Journal:  Brain Res Mol Brain Res       Date:  1996-11

5.  Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits.

Authors:  T Ishii; K Moriyoshi; H Sugihara; K Sakurada; H Kadotani; M Yokoi; C Akazawa; R Shigemoto; N Mizuno; M Masu
Journal:  J Biol Chem       Date:  1993-02-05       Impact factor: 5.157

Review 6.  A thalamo-hippocampal-ventral tegmental area loop may produce the positive feedback that underlies the psychotic break in schizophrenia.

Authors:  John E Lisman; Hyun Jae Pi; Yuchun Zhang; Nonna A Otmakhova
Journal:  Biol Psychiatry       Date:  2010-05-31       Impact factor: 13.382

Review 7.  GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia.

Authors:  Guillermo Gonzalez-Burgos; David A Lewis
Journal:  Schizophr Bull       Date:  2008-06-26       Impact factor: 9.306

8.  Schizophrenia-like GABAergic gene expression deficits in cerebellar Golgi cells from rats chronically exposed to low-dose phencyclidine.

Authors:  W Michael Bullock; Federico Bolognani; Paolo Botta; C Fernando Valenzuela; Nora I Perrone-Bizzozero
Journal:  Neurochem Int       Date:  2009-08-03       Impact factor: 3.921

9.  Differential effects of NMDA antagonists on high frequency and gamma EEG oscillations in a neurodevelopmental model of schizophrenia.

Authors:  K G Phillips; M C Cotel; A P McCarthy; D M Edgar; M Tricklebank; M J O'Neill; M W Jones; K A Wafford
Journal:  Neuropharmacology       Date:  2011-04-19       Impact factor: 5.250

10.  Effects of NMDA receptor antagonists and antipsychotics on high frequency oscillations recorded in the nucleus accumbens of freely moving mice.

Authors:  Mark J Hunt; Maciej Olszewski; Joanna Piasecka; Miles A Whittington; Stefan Kasicki
Journal:  Psychopharmacology (Berl)       Date:  2015-10-08       Impact factor: 4.530

View more
  25 in total

1.  The NMDA receptor intracellular C-terminal domains reciprocally interact with allosteric modulators.

Authors:  Kiran Sapkota; Kim Dore; Kang Tang; Mark Irvine; Guangyu Fang; Erica S Burnell; Roberto Malinow; David E Jane; Daniel T Monaghan
Journal:  Biochem Pharmacol       Date:  2018-11-29       Impact factor: 5.858

Review 2.  Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research.

Authors:  Maria R Dauvermann; Graham Lee; Neil Dawson
Journal:  Br J Pharmacol       Date:  2017-08-11       Impact factor: 8.739

Review 3.  Convergent Mechanisms Underlying Rapid Antidepressant Action.

Authors:  Panos Zanos; Scott M Thompson; Ronald S Duman; Carlos A Zarate; Todd D Gould
Journal:  CNS Drugs       Date:  2018-03       Impact factor: 5.749

4.  Tonic Activation of GluN2C/GluN2D-Containing NMDA Receptors by Ambient Glutamate Facilitates Cortical Interneuron Maturation.

Authors:  Elizabeth Hanson; Moritz Armbruster; Lauren A Lau; Mary E Sommer; Zin-Juan Klaft; Sharon A Swanger; Stephen F Traynelis; Stephen J Moss; Farzad Noubary; Jayashree Chadchankar; Chris G Dulla
Journal:  J Neurosci       Date:  2019-03-07       Impact factor: 6.167

5.  The Role of GluN2C-Containing NMDA Receptors in Ketamine's Psychotogenic Action and in Schizophrenia Models.

Authors:  Elizaveta Khlestova; Jon W Johnson; John H Krystal; John Lisman
Journal:  J Neurosci       Date:  2016-11-02       Impact factor: 6.167

6.  NMDA receptors containing GluN2C and GluN2D subunits have opposing roles in modulating neuronal oscillations; potential mechanism for bidirectional feedback.

Authors:  Zhihao Mao; Shengxi He; Christopher Mesnard; Paul Synowicki; Yuning Zhang; Lucy Chung; Alex I Wiesman; Tony W Wilson; Daniel T Monaghan
Journal:  Brain Res       Date:  2019-11-28       Impact factor: 3.252

7.  A Role for Prefrontal Cortical NMDA Receptors in Murine Alcohol-Heightened Aggression.

Authors:  Emily L Newman; Miho Terunuma; Tiffany L Wang; Nishani Hewage; Matthew B Bicakci; Stephen J Moss; Joseph F DeBold; Klaus A Miczek
Journal:  Neuropsychopharmacology       Date:  2017-10-20       Impact factor: 7.853

8.  Discovery of Dihydropyrrolo[1,2-a]pyrazin-3(4H)-one-Based Second-Generation GluN2C- and GluN2D-Selective Positive Allosteric Modulators (PAMs) of the N-Methyl-d-Aspartate (NMDA) Receptor.

Authors:  Matthew P Epplin; Ayush Mohan; Lynnea D Harris; Zongjian Zhu; Katie L Strong; John Bacsa; Phuong Le; David S Menaldino; Stephen F Traynelis; Dennis C Liotta
Journal:  J Med Chem       Date:  2020-07-06       Impact factor: 7.446

Review 9.  The origin of NMDA receptor hypofunction in schizophrenia.

Authors:  Kazu Nakazawa; Kiran Sapkota
Journal:  Pharmacol Ther       Date:  2019-10-16       Impact factor: 12.310

10.  RETRACTED: Mnemonic Discrimination Deficits in First-Episode Psychosis and a Ketamine Model Suggests Dentate Gyrus Pathology Linked to N-Methyl-D-Aspartate Receptor Hypofunction.

Authors:  Nina Vanessa Kraguljac; Matthew Carle; Michael A Frölich; Steve Tran; Michael A Yassa; David Matthew White; Abhishek Reddy; Adrienne Carol Lahti
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.